To require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks, and for other purposes.
Sponsors
Gary C. Peters
D-MI | Primary Sponsor
Legislative Progress
IntroducedMr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
Mr. Peters (for himself and Ms. Ernst) introduced the following …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology